Fintel reports that on September 10, 2025, Citigroup upgraded their outlook for Oracle (NYSE:ORCL) from Neutral to Buy.

Analyst Price Forecast Suggests 22.81% Downside

As of September 2, 2025, the average one-year price target for Oracle is $253.53/share. The forecasts range from a low of $176.75 to a high of $341.25. The average price target represents a decrease of 22.81% from its latest reported closing price of $328.44 / share.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Oracle is 59,330MM, an increase of 0.53%. The projected annual non-GAAP EPS is 7.35, a decrease of 1.36% from the prior forecast.

What is the Fund Sentiment?

There are 5,066 funds or institutions reporting positions in Oracle. This is an increase of 390 owner(s) or 8.34% in the last quarter. Average portfolio weight of all funds dedicated to ORCL is 0.72%, an increase of 20.37%. Total shares owned by institutions increased in the last three months by 1.48% to 1,457,567K shares. The put/call ratio of ORCL is 0.76, indicating a bullish outlook.

What are Other Shareholders Doing?

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 54,104K shares representing 1.93% ownership of the company. In its prior filing, the firm reported owning 53,016K shares , representing an increase of 2.01%. The firm increased its portfolio allocation in ORCL by 42.38% over the last quarter.

VFINX - Vanguard 500 Index Fund Investor Shares holds 46,168K shares representing 1.64% ownership of the company. In its prior filing, the firm reported owning 45,076K shares , representing an increase of 2.37%. The firm increased its portfolio allocation in ORCL by 42.30% over the last quarter.

Jpmorgan Chase holds 45,650K shares representing 1.63% ownership of the company. In its prior filing, the firm reported owning 43,033K shares , representing an increase of 5.73%. The firm increased its portfolio allocation in ORCL by 48.56% over the last quarter.

Geode Capital Management holds 36,323K shares representing 1.29% ownership of the company. In its prior filing, the firm reported owning 37,583K shares , representing a decrease of 3.47%. The firm increased its portfolio allocation in ORCL by 34.56% over the last quarter.

Capital Research Global Investors holds 23,044K shares representing 0.82% ownership of the company. In its prior filing, the firm reported owning 19,011K shares , representing an increase of 17.50%. The firm increased its portfolio allocation in ORCL by 74.54% over the last quarter.